AU2003279747A1 - Sh2 domain binding inhibitors - Google Patents

Sh2 domain binding inhibitors

Info

Publication number: AU2003279747A1
Authority: AU; Australia
Prior art keywords: domain binding; binding inhibitors; inhibitors; domain; binding
Prior art date: 2002-06-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003279747A

Other versions

AU2003279747A8 (en

Inventor

Terrence R. Burke Jr.

Yang Gao

Zhen-Dan Shi

Johannes H. Voigt

Chang-Qing Wei

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

US Department of Health and Human Services

Original Assignee

US Department of Health and Human Services

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-28

Filing date

2003-06-26

Publication date

2004-01-19

2003-06-26 Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services

2004-01-19 Publication of AU2003279747A8 publication Critical patent/AU2003279747A8/en

2004-01-19 Publication of AU2003279747A1 publication Critical patent/AU2003279747A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/123—Tripeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AU2003279747A 2002-06-28 2003-06-26 Sh2 domain binding inhibitors Abandoned AU2003279747A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US39202802P	2002-06-28	2002-06-28
US60/392,028		2002-06-28
PCT/US2003/019987 WO2004003005A2 (en)	2002-06-28	2003-06-26	Sh2 domain binding inhibitors

Publications (2)

Publication Number	Publication Date
AU2003279747A8 AU2003279747A8 (en)	2004-01-19
AU2003279747A1 true AU2003279747A1 (en)	2004-01-19

Family

ID=30000798

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003279747A Abandoned AU2003279747A1 (en)	2002-06-28	2003-06-26	Sh2 domain binding inhibitors

Country Status (2)

Country	Link
AU (1)	AU2003279747A1 (en)
WO (1)	WO2004003005A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050119163A1 (en)	2003-09-18	2005-06-02	The Government Of The United States Of America, As Represented By The Secretary,	SH2 domain binding inhibitors
CA2582908A1 (en) *	2004-09-30	2006-04-13	Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services	Macrocyclic sh2 domain binding inhibitors
FR2901917B1 (en)	2006-05-31	2008-12-19	Thales Sa	CIRCULATOR RADIO FREQUENCY OR HYPERFREQUENCY
WO2008067270A1 (en) *	2006-11-27	2008-06-05	Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Macrocyclic grb2 sh2 domain-binding inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001028577A2 (en) *	1999-10-22	2001-04-26	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
CA2419870A1 (en) *	2000-08-22	2002-02-28	Yang Gao	Sh2 domain binding inhibitors

2003
- 2003-06-26 AU AU2003279747A patent/AU2003279747A1/en not_active Abandoned
- 2003-06-26 WO PCT/US2003/019987 patent/WO2004003005A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2003279747A8 (en)	2004-01-19
WO2004003005A2 (en)	2004-01-08
WO2004003005A3 (en)	2007-02-01

Publication	Publication Date	Title
AU2003202263A1 (en)	2003-07-30	Roh-kinase inhibitors
AU2003249442A1 (en)	2004-02-16	Kinase inhibitors
AU2003222055A1 (en)	2003-10-08	Kinase inhibitors
AU2003902828A0 (en)	2003-06-26	Dpp-iv inhibitor
AU2003902946A0 (en)	2003-06-26	Dpp-iv inhibitor
AU2003259749A1 (en)	2004-02-25	3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003303483A1 (en)	2004-07-22	Ccr8 inhibitors
AU2003902260A0 (en)	2003-05-29	Dpp-iv inhibitor
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
AU2003271566A1 (en)	2004-03-03	Pyrrolopyrazines as kinase inhibitors
AU2003225523A1 (en)	2003-09-02	Functional pipelines
AU2003900608A0 (en)	2003-02-27	Hdac inhibitor
AU2003300832A1 (en)	2004-06-30	NF-KappaB INHIBITORS
AU2003217341A1 (en)	2003-09-09	Time domain reflectometry
AU2003299883A1 (en)	2004-07-22	Ccr8 inhibitors
AU2003238042A1 (en)	2004-01-06	Cyclooxygenase-2 inhibitors
AU2003249683A1 (en)	2003-12-22	Nf-:b inhibitors
AU2003233426A1 (en)	2003-10-13	Corrosion inhibitor
AU2003220437A1 (en)	2003-10-08	Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003230392A1 (en)	2003-12-12	Beta-secretase inhibitors
AU2003302588A1 (en)	2004-06-23	Phosphodiesterase 10a inhibitors
AU2003298810A1 (en)	2004-08-23	NF-kB INHIBITORS AND USES THEREOF
AU2002224550A1 (en)	2002-02-05	Corrosion inhibitors
AU2003224941A1 (en)	2003-10-27	NF-KappaB INHIBITORS
AU2003900587A0 (en)	2003-02-27	Hdac inhibitor

Legal Events

Date	Code	Title	Description
2005-07-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase